Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
McKinsey
Medtronic
US Department of Justice
Colorcon

Generated: May 25, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,737,168

« Back to Dashboard

Which drugs does patent 7,737,168 protect, and when does it expire?

Patent 7,737,168 protects TPOXX and is included in one NDA.

This patent has twenty-seven patent family members in ten countries.

Summary for Patent: 7,737,168
Title:Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
Abstract: Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases cased by the orthopoxvirus.
Inventor(s): Jordan; Robert (Corvallis, OR), Bailey; Thomas R. (Pheonixville, PA), Rippin; Susan R. (Wilmington, DE)
Assignee: Siga Technologies, Inc. (Corvallis, OR)
Application Number:10/561,153
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,737,168
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 7,737,168

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF HUMAN SMALLPOX DISEASE CAUSED BY VARIOLA VIRUS IN ADULTS AND PEDIATRIC PATIENTS WEIGHING AT LEAST 13 KG ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,737,168

PCT Information
PCT FiledJune 18, 2004PCT Application Number:PCT/US2004/019552
PCT Publication Date:December 29, 2004PCT Publication Number: WO2004/112718

International Family Members for US Patent 7,737,168

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004249250 ➤ Try a Free Trial
Australia 2007351866 ➤ Try a Free Trial
Canada 2529761 ➤ Try a Free Trial
Canada 2685153 ➤ Try a Free Trial
Canada 2685198 ➤ Try a Free Trial
Canada 2866037 ➤ Try a Free Trial
Canada 2966466 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Chinese Patent Office
Express Scripts
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.